Otc - Active Ingredient
Drug Facts
Peppermint Oil 13mg
Sage Oil 5.3mg
As.edema prevention and swelling relieving.
Swelling Solution
FDA Label NDC 70470-8003
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Phytopia Co., Ltd. for the product Swelling Solution (NDC 70470-8003). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, dosage & administration, indications & usage, inactive ingredient, otc - pregnancy or breast feeding, otc - keep out of reach of children, warnings, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Otc - Purpose
Use
Helps to reduce water retention. Specially designed for improving lymphatic drainage.
Dosage & Administration
Dosage Suggestion
Adults 5ml Maximum Per Day
Indications & Usage
Directions
Apply on skin and massage around the whole body.
Inactive Ingredient
Other Ingredients
Citrus Limon Fruit Oil, Grape Seed Oil, Jojoba Oil, Sunflower Oil, Sweet Marjoram Oil, Olive Oil,
Pine Needle Oil (Pinus Sylvestris).
Otc - Pregnancy Or Breast Feeding
Warnings
For external use only. Stop use and ask doctor if rash occurs. Keep out of reach of children. Do not use during pregnancy.
Otc - Keep Out Of Reach Of Children
Warnings
For external use only. Stop use and ask doctor if rash occurs. Keep out of reach of children. Do not use during pregnancy.
Warnings
Warnings
For external use only. Stop use and ask doctor if rash occurs. Keep out of reach of children. Do not use during pregnancy.
Storage And Handling
Other Information
Protect this product from excessive heat and direct sun.
Package Label.Principal Display Panel
Swelling Solution- improving lymphatic drainage.
* Please review the disclaimer below.
